… Chronic kidney disease (CKD) is highly prevalent in patients with chronic heart failure (CHF…
optimization of standard pharmacologic therapy for heart failure. Therefore, other treatment …

… benefits and adverse effects of sacubitril/valsartan in heart failure, with a focus on important
… comparing sacubitril/valsartan versus a reference drug, in heart failure patients with reduced (…

… Sacubitril/valsartan is a first-in-class angiotensin receptor-… mortality in patients with chronic,
symptomatic heart failure (HF) … the implementation of sacubitril/valsartan in clinical practice, …

… Given the limited evidence of the impact of sacubitril/valsartan treatment on the … chronic
heart failure, we conducted a retrospective analysis in patients treated with sacubitril/valsartan at …

… progression in ACHD heart failure management would be … novel pathway in the ACHD heart
failure population. The aim of … sacubitril-valsartan use in ACHD patients with chronic NYHA …

… of sudden death in patients with heart failure (HF) and reduced … inhibitor sacubitril/valsartan
induces favorable ventricular … We investigated the impact of sacubitril/valsartan initiation on …

… in the treatment of patients with chronic heart failure (HF) with reduced ejection fraction (HFrEF).1
In the PARADIGM-HF trial, sacubitril/valsartan was found to be superior to the …

… for patients with chronic heart failure (CHF)… valsartan (LCZ696) has been recently approved
for CHF patients as it reduces cardiovascular (CV) deaths and hospitalization for heart failure …

… with sacubitril/valsartan reduced the primary outcome of cardiovascular (CV) death and
heart failure (HF) hospitalization compared with enalapril in patients with chronic HF and …

… Sixty consecutive patients with chronic heart failure and NYHA class II-III were followed up
for 12 months after therapy with sacubitril/valsartan. Left and (RV) function was assessed at …